Article Details
Retrieved on: 2024-12-09 18:10:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Meanwhile, Roche's RO five-year follow-up data from the phase 3 Polarix study, which tested the combination of Polivy and rituximab ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here